Asia-Pacific Topical Skin Adhesive Market – Industry Trends and Forecast to 2030

Asia-Pacific Topical Skin Adhesive Market, By Product Type (Cyanoacrylate, Methylidene Malonate, and Others), Application (Wound Closure, Trauma-Induced Lacerations, and Burn and Skin Grafting), End User (Hospitals, Trauma Centers, Ambulatory Surgical Centers, Clinics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2030.

Asia-Pacific Topical Skin Adhesive Market Analysis and Size

The Asia-Pacific topical skin adhesive market is fragmented in nature, as it consists of many global players such as Johnson & Johnson (Medical Devices Business Services, Inc.), Advanced Medical Solutions Group plc,  Cardinal Health., 3M, Medtronic, B. Braun SE, and DuPont. among others. The presence of these companies produces competitive prices for topical skin adhesive products across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising incidences of burn injuries and skin diseases are driving the market growth. Additionally, the growing expenses for the development of healthcare infrastructure are expected to drive market growth.

Data Bridge Market Research analyzes that the Asia-Pacific topical skin adhesive market is expected to reach the value of USD 802.94 million by 2030, at a CAGR of 5.31% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Market Definition

The topical skin adhesives (or glues) are liquid cyanoacrylate monomers that polymerize into long solid chains upon contact with blood or a wound surface, thus holding wound edges together. Topical skin adhesives are ideal for simple cuts such as punctures from minimally invasive surgery (for example hair transplantation), skin graft sites, and simple trauma-induced lacerations. However, topical skin adhesives cannot be used on all cuts. They are generally not used on infected or gangrenous wounds and patients with a known hypersensitivity/allergy to cyanoacrylate or formaldehyde. The key benefits of topical skin adhesives include fast and painless procedure, do not leave any hatch marks (unlike sutures and staples), which results in excellent cosmetic outcomes, do not require a follow-up procedure to remove them after their purpose has been achieved — topical skin adhesives simply slough off spontaneously after 5 to 10 days, eliminate the fear and risk of needle sticks, create a moist environment, which provides the optimal condition for wound healing and have antimicrobial features against gram-positive organisms so less risk of wound infection. The growth of the Asia-Pacific topical skin adhesive market is primarily driven by the increasing number of surgical procedures due to accidental injuries.

Asia-Pacific Topical Skin Adhesive Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

• Rising Incidences of Burn Injuries and Skin Diseases

Thermal injuries are physically painful and may leave disabling scars not only on the skin or the body, but also impair psychological well-being. Severe injuries often impose significant psychological, but also educational consequences and social stigmatization. Asian countries, especially high-income countries, had a high burden of inflammatory dermatoses, including acne, alopecia areata, atopic dermatitis, contact dermatitis, decubitus ulcers, psoriasis, pruritus, and seborrheic dermatitis. The burden of infectious dermatoses was greater in low-income Asian countries. Hence, the rising incidence of burn injuries and skin diseases is expected to drive market growth.

• Growing Expenses on the Development of Healthcare Infrastructure

Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good experience of the healthcare system. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population. Infrastructure must integrate the hospital, as the center for acute and inpatient care, into the broader healthcare system and should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements: equipment, access, Information Technology (IT), systems and processes, sustainability initiatives, and staff.

OPPORTUNITY

• Faster Recovery and Restoration

The stiff competition and growing healthcare infrastructure help in providing better skin care, which leads to faster recovery and restoration into normal life. As technology and innovations in healthcare are increasing, people are getting more aware and desire advanced or quick care of their health for treatment and cure. The use of tissue adhesive and adhesive strips for wound closure is now commonplace in many emergency departments, though each has its limitations and practical difficulties. The skin adhesive has numerous potential applications in the medical field either as a patch that can be cut to desired sizes and applied to many tissues including bone, cartilage, tendon, or pleura or as an injectable solution for deeper injuries. The skin adhesive can also be used to attach medical devices to their target structures such as an actuator to support heart function.

RESTRAINT/CHALLENGE

• Lack of Standard Regulatory Guidelines and Non-Favourable Reimbursement Scenario

Even after a company obtains regulatory approval to market a product, the product and the company’s manufacturing processes and quality systems are subjected to continual review by the FDA and other regulatory authorities. The interests and safety of the public must therefore be entrusted to a regulatory body or bodies that ensure that only products in legal trade are available and that marketed products are safe. The regulation of medical products has become increasingly complex with the globalization of product development, production, and supply and the rapid pace of technological and social change in the context of limited financial and human resources. Also, the lack of reimbursement scenarios in developing countries is observed.

Hence, the lack of standard regulatory guidelines and non-favorable reimbursement scenarios for topical skin adhesive products may restrain market growth in the forecast period.

Post-COVID-19 Impact on the Asia-Pacific Topical Skin Adhesive Market

COVID-19 created a negative impact on the Asia-Pacific topical skin adhesive market due to the shutdown of global manufacturing sectors, logistics and transportation, and lack of testing for the product.

The COVID-19 pandemic has impacted the market negatively to an extent. However, increasing government support and continuous technological advancement is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players and the growing awareness of skin adhesive products in the region are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple R&D activities to improve the technology involved in the product. With this, the companies will bring advancement and innovation to the market.

Recent Developments

• In November 2020, Advanced Medical Solutions Group plc acquired Raleigh Adhesive Coatings Limited, which is an independent wound care and bio-diagnostics coatings business based in the U.K.
• In January 2023, Cardinal Health. teamed up with Palantir Technologies Inc. a leading builder of operating systems for the modern enterprise, to design a solution that will give health systems and hospitals dynamic purchase decision insights in order to quickly improve their bottom line.

Asia-Pacific Topical Skin Adhesive Market Scope

The Asia-Pacific topical skin adhesive market is segmented into four notable segments based on product type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Cyanoacrylate
• Methylidene Malonate
• Others

Based on product type, the market is segmented into cyanoacrylate, methylidene malonate, and others.

Application

• Wound Closure
• Trauma-Induced Lacerations
• Burn and Skin Grafting

Based on application, the market is segmented into wound closure, trauma-induced lacerations, and burn and skin grafting.

End User

• Hospitals
• Trauma Centers
• Ambulatory Surgical Centers
• Clinics
• Others

Based on end user, the market is segmented into hospitals, trauma centers, ambulatory surgical centers, clinics, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Others

Based on distribution channel, the market is segmented into direct tender, retail sales, and others.

Asia-Pacific Topical Skin Adhesive Market Regional Analysis/Insights

The Asia-Pacific topical skin adhesive market is analyzed and market size insights and trends are provided by country, product type, application, end user, and distribution channel as referenced above.

The countries covered in this market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and rest of Asia-Pacific.

Japan is dominating the market with the largest market share. This share is attributable to the presence of key market players such as Johnson & Johnson (Medical Devices Business Services, Inc.),  Advanced Medical Solutions Group plc, and Cardinal Health. among others. Increasing investments in healthcare infrastructure and penetration of new technologies are anticipated to fuel the market growth during the forecast period in the country.

The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Topical Skin Adhesive Market Share Analysis

The Asia-Pacific topical skin adhesive market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the Asia-Pacific topical skin adhesive market are Johnson & Johnson (Medical Devices Business Services, Inc.),  Advanced Medical Solutions Group plc,  Cardinal Health., 3M and Medtronic, B. Braun SE, DuPont., Vygon, LifeHealthcare and Medline Industries, LP, Nissha Medical Technologies, Chemence Medical, Inc., E-XCLUSIF MEDICAL SUPPLY PTE LTD., SURGITECH INNOVATION, GluStitch, and  Alfa Pharma GmbH among others.